Skip to main content

Table 2 Descriptive statistics for the measurement results before and after thiamazole therapy (not all subjects have both measurements)

From: Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels

 

Mean

Median

SD

Min

Max

p-value

anti-TPO – before [IU/ml]

222.7

21.8

356.0

5

1000

-

anti-Tg – before [IU/ml]

109.2

20.2

222.7

10

803

-

anti-TSHR – before [IU/l]

7.6

1.3

11.6

0.3

40.0

0.999

anti-TSHR – after [IU/l]

11.9

10.9

5.9

6.6

18.3

 

TSH - before [mIU/l]

0.0

0.0

0.0

0.0

0.0

0.013

TSH – after [mIU/l]

1.1

0.0

1.7

0.0

5.8

 

FT3 – before [pg/ml]

8.74

7.53

4.79

4.02

16.5

0.0010

FT3 – after [pg/ml]

3.49

3.54

2.40

0.74

4.8

 

FT4 – before [ng/ml]

4.48

2.21

1.01

7.84

32.5

0.0010

FT4 – after [ng/ml]

1.02

1.07

0.44

0.34

1.7

 

Sclerostin- before [pmol/l]

55.46

41.90

20.90

39.29

148.8

0.0015

Sclerostin – after [pmol/l]

35.73

27.20

15.70

23.46

99.6

 
  1. P-value for the Mann–Whitney`s U test for a comparison of pairs of measurement results before and after antithyroid therapy (where appropriate).